QA: Hepion Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583771_2026_Hepion_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001583771, Hepion Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 3,069,952
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 299,383
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 103,022
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,876,975
9 ResearchAndDevelopmentExpense -5,805,014
10 remainder_Expenses 315,723
11 remainder_Revenues 0
12 remainder_NetIncome 4,510,289
13 remainder_ComprehensiveNetIncome 21,878
  yvar yval
0 Assets 3,069,952
1 Liabilities 402,405
2 Expenses -2,612,316
3 Revenues 0
4 StockholdersEquity 2,667,547
5 NetIncome 7,122,605
6 ComprehensiveNetIncome 7,133,544
7 BaseVar 5,308,420
8 EconomicCapitalRatiobeforeLimitedLiability 7.46
9 EconomicCapitalRatio 7.47

Edgar->Model Mapping

Feature Distribution

Change over Time